Abstract:Clinical significance of combined detection of CCL22 and IL‐1 as potential new bronchial inflammatory mediators in children asthma. Backgrounds Severe asthma is a significant health burden because children with severe asthma are vulnerable to medication‐related side effects, life‐threatening deterioration, and impaired quality of life. However, there is a lack of data to elucidate the role of inflammatory variables in asthma. This study aimed to compare the levels of inflammatory factors in serum and sputum in children with acute and stable asthma to those in healthy children and the ability to predict clinical response to azithromycin therapy. Methods This study recruited 95 individuals aged 1−3 years old and collected data from January 2018 to 2020. We examined serum and sputum inflammatory factors and constructed the least absolute shrinkage and selection operator (LASSO) model. Predictive models were constructed through multifactor logistic regression and presented in the form of column‐line plots. The performance of the column‐line diagrams was measured by subject work characteristics (ROC) curves, calibration plots, and decision curve analysis (DCA). Then, filter‐paper samples were collected from 45 children with acute asthma who were randomly assigned to receive either azithromycin (10 mg/kg, n = 22) or placebo (n = 23). Pretreatment levels of immune mediators were then analyzed and compared with clinical response to azithromycin therapy. Results Of the 95 eligible participants, 21 (22.11%) were healthy controls, 29 (30.53%) had stable asthma, and 45 (47.37%) had acute asthma. The levels of interferon‐γ (IFN‐γ), tumor necrosis factor‐a (TNF‐α), chemokine CCL22 (CCL22), interleukin 12 (IL‐12), chemokine CCL4 (CCL4), chemokine CCL2 (CCL2), and chemokine CCL13 (CCL13)were significantly higher in the acute asthma group than in the stable asthma group. A logistic regression analysis was performed using CCL22 and IL‐1 as independent variables. Additionally, IFN‐γ, TNF‐α, IL‐1, IL‐13, and CCL22 were identified in the LASSO model. Finally, we found that CCL22 and IL‐1 were more responsive in predicting the response to azithromycin treatment. Conclusion Our results show that CCL22 and IL‐1 are both representative markers during asthma symptom exacerbations and an immune mediator that can predict response to azithromycin therapy.

Relationship Between Imbalance of Suppressors of Cytokine Signaling 1/suppressors of Cytokine Signaling 3 and Abnormal Activation of Monocytes/Macrophages in Children with Asthma

Assessment of serum inflammatory cytokines and oxidative stress in asthma children

Expression of Transcription Factor and Cytokine of Th1/Th2 in Children with Asthma in Remission Stage

Clinical Significance of Combined Detection of CCL22 and IL‐1 as Potential New Bronchial Inflammatory Mediators in Children's Asthma

Changs of B7 Family Costimulatory Molecules and Their Receptors Expression in Children with Asthma

[Changes of Regulatory T Cells and T Helper Cells in Peripheral Blood and Their Roles in the Severity Evaluation in Children with Asthma].

Expressions of CD4~+CD_(45)RA and CD4~+CD_(45)RO in Peripheral Blood CD4~+T Lymphocytes in Children with Bronchial Asthma

Suppressor of Cytokine Signaling-1 and Lung Diseases

Regulatory T Cells and Th1/Th2 in Peripheral Blood and Their Roles in Asthmatic Children.

The Change of Lymphocyte Subsets and Its Significance in Children with Asthma Attack

CD4+ CD25+ regulatory T cells and expressions of forkhead/winged helix transcription factor ( Foxp 3 ) mRNA in peripheral blood of patients with asthma

Correlation investigation of signal molecule CD40/CD40L and children asthma

The Changes of Regulatory T Cells and T Helper Cell in Peripheral Blood and Their Significance in Patients with Asthma

An increased ratio of Th2/Treg cells in patients with moderate to severe asthma.

Analysis of CD4 + CD25 + regulatory T cells and Foxp3 mRNA in the peripheral blood of patients with asthma

Changes in Levels of IL-9, IL-17, IFN-γ, Dendritic Cell Numbers and TLR Expression in Peripheral Blood in Asthmatic Children with Mycoplasma Pneumoniae Infection.

Translational Study on the Relationships Between Body Mass Index, Levels of Serum Inflammatory Factors and Bronchial Asthma in Children

Aberrant expression of suppressor of cytokine signaling (SOCS) molecules contributes to the development of allergic diseases

Single-cell RNA sequencing unraveled the expression heterogeneity of hematopoietic stem and progenitor cells and lymphoid cell development dysregulation in childhood asthma

Single-cell RNA sequencing unraveled the expression heterogeneity of hematopoietic stem and progenitor cells and immune cell development dysregulation in childhood asthma

Interfering with alternatively activated macrophages by CSF-1R inhibition exerts therapeutic capacity on allergic airway inflammation